Economic shockwaves caused by Covid-19 have plunged stock markets into turmoil, but some shares are better able to absorb this volatility than others - ...
JP Morgan Cazenove today reaffirms its overweight investment rating on Smiths Group PLC [LON:SMIN] and raised its price target to 1500p (from 1300p).
While the planned separation of Smiths Medical was on track to be delivered by the end of the first half of 2020, the group said now “it is simply not practicable to complete the separation in current ...
It saw full-year performance in line with previous expectations. Smiths Group (LON:SMIN) said revenue from continuing operations rose 11% in the first quarter of its fiscal year thanks to strong ...
StockMarketWire.com - RBC Capital Markets today reaffirms its underperform investment rating on Smiths Group PLC [LON:SMIN] and raised its price target to 1550p (from 1500p).
StockMarketWire.com - JP Morgan Cazenove today reaffirms its overweight investment rating on Smiths Group PLC [LON:SMIN] and raised its price target to 1835p (from 1760p).
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Smiths Group plc (LON:SMIN) is a company with exceptional fundamental ...
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you want to know who really controls Smiths Group plc (LON:SMIN ...
There's an exclusive group of shares in the stock market that most investors would love to own. They've got stellar track records, sparkling reputations and the ability to deliver stunning returns ...
Smiths Group (LON:SMIN) had its price objective reduced by research analysts at Royal Bank of Canada from GBX 1,530 ($19.99) to GBX 1,500 ($19.60) in a research report issued to clients and investors ...
British engineering firm Smiths Group will spin off its struggling medical business and list it separately on the London Stock Exchange, the company said today. Smiths had unveiled plans for a ...
Dunelm Group: JP Morgan downgrades to neutral with a target price of 620p.
Paragon: Numis upgrades to buy with a target price of 452p.
Smiths Group confirmed on Tuesday that it is in very early stage discussions about a potential combination of its medical division with Nasdaq-listed ICU Medial.
UK stocks are looking attractive amid renewed sterling weakness and potential turning tide after years of being under-held by fund managers, said BoA Merrill Lynch on Friday, highlighting particular value in Ashtead, GVC Holdings, National Grid, Standard Chartered and RSA Insurance.
Smiths Group was a 'hold' for the Sunday Times' Inside the City column as chief executive Andy Reynolds Smith puts his shirt on full-year results from the engineering conglomerate in the autumn.
RBS: Deutsche Bank upgrades to buy with a target price of 305p.
Smiths Group tumbled on Friday after it posted a 12% drop in interim profit as revenue fell and while the engineering company did reiterate its guidance for the year, it also warned that forex headwinds would persist.
Just Eat: Deutsche Bank downgrades to sell with a target price of 630p.
Barclays initiated coverage of diversified engineer Smiths Group at 'overweight', with an 1,800p price target as it highlighted material change under the current management team.